Come up with a name for your new list and we'll add to it:
Cytochroma raised a round of funding on December 04, 2002. Investors include
VenGrowth Capital Partners.
Cytochroma is a clinical-stage specialty pharmaceutical company focused on developing and commercializing products to treat and prevent the clinical consequences of vitamin D insufficiency and SHPT as…